{"doi":"10.1101/2022.08.01.502242","title":"Full-length optic nerve regeneration in the absence of genetic manipulations","abstract":"Summary The inability of mature retinal ganglion cells (RGCs) to regenerate axons after optic nerve injury can be partially reversed by manipulating cell-autonomous and/or -non-autonomous factors, among which are neuroimmune interactions. We report here that preconditioning resulting from a mild lens injury (conditioning LI, cLI) prior to optic nerve damage induces far greater axon regeneration than LI or the pro-inflammatory agent zymosan after nerve injury or preconditioning with Zymosan. Unlike other instances of immune-supported regeneration, cLI is unaltered by depleting mature neutrophils, T cells or blocking receptors for identified inflammation-associated growth factors (Oncomodulin, SDF1, CCL5), and is only partially diminished by suppressing peripheral monocyte recruitment. Repeated LI leads to full-length optic nerve regeneration, and pharmacological removal of local resident macrophages with the colony stimulating factor 1 receptor (CSF-1R) inhibitor PLX5622 enables some axons to re-innervate the brain in just 6 weeks. Thus, cell non-autonomous interventions not involving genetic manipulations can induce high levels of optic nerve regeneration, paving the way to uncover potent, translatable therapeutic targets for CNS repair.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2022,"id":310424,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9593,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":351056,"name":"Kimberly A. Wong","orcid":"0000-0003-3335-2849","position":1,"is_corresponding":false},{"id":477407,"name":"Larry I. Benowitz","orcid":"0000-0002-0277-7222","position":2,"is_corresponding":false},{"id":1005666,"name":"Qian Feng","orcid":"0000-0002-5504-9843","position":0,"is_corresponding":true}],"reference_count":41,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T00:33:19.712967Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}